Marketing channel feed

GSK asks US patent of­fice to refuse Mod­er­na’s ‘Covid Mvax’ trade­mark reg­is­tra­tion as 'too gener­ic'

Last year
Pharma

Hori­zon, Roche top list for phar­ma rep­u­ta­tion among rare dis­ease pa­tient groups, sur­vey finds

Last year
Pharma

Mar­ket­ingRx roundup: Alzheimer’s As­so­ci­a­tion rais­es aware­ness in His­pan­ic com­mu­ni­ty; Can­cer re­search fundrais­er tops $795M

Last year
Pharma

Slynd birth con­trol drug­mak­er Ex­eltis hit with FDA let­ter over mis­lead­ing so­cial me­dia pro­mo­tion

Last year
FDA+

Ab­b­Vie ex­plores the emo­tion­al side of rare chron­ic can­cer in on­go­ing CLL video se­ries

Last year
Pharma

Mul­ti-task­ing doc­tors at home are watch­ing TV and re­search­ing phar­ma ads — on Google and even EMRs, sur­vey finds

Last year
Pharma

Gilead tracks five years of HIV grant giv­ing in hard-hit US South, and dou­bles down on new ap­proach­es

Last year
Pharma

Ab­b­Vie rais­es aware­ness around men­tal health and skin con­di­tions with pa­tients, docs and a celebri­ty spokesper­son

Last year
Pharma

FDA pro­mo­tions watch­dog de­liv­ers first warn­ing let­ter of the year to As­traZeneca over Breztri mar­ket­ing

Last year
Pharma
FDA+

Mar­ket­ingRx roundup: Pfiz­er teams with Food Net­work star; Bris­tol My­ers earns 'bil­lion dol­lar' dis­tinc­tion

Last year
Pharma

How Ex­act Sci­ences' out-of-the-box think­ing con­vinced Amer­i­cans to try Co­lo­guard's col­orec­tal can­cer screen­ing test

Last year
Pharma

Am­gen takes a light­heart­ed ap­proach in lat­est Ote­zla cam­paign around mild-to-mod­er­ate pso­ri­a­sis

Last year
Pharma

Bris­tol My­ers de­buts cor­po­rate brand ‘an­them’ film on dig­i­tal and so­cial chan­nels, cel­e­brat­ing its sci­ence and peo­ple

Last year
Pharma

Phar­ma com­pa­nies look to tap med­ical so­cial in­flu­encers in new agency part­ner­ship

Last year
R&D

RSV mar­ket­ing bat­tle shap­ing up with GSK and Pfiz­er cam­paigns run­ning on TV, dig­i­tal chan­nels ahead of the vi­ral sea­son

Last year
Pharma

Genen­tech adopts racial jus­tice lens for new fund­ing that goes be­yond typ­i­cal health eq­ui­ty grants

Last year
Pharma

Evo­lus puts on 'y­outh­ful' new look for frown line treat­ment Jeu­veau

Last year
Pharma

Mar­ket­ingRx roundup: An­a­lyst group finds no ‘ob­vi­ous’ link to GLP-1s and sui­ci­dal ideation; Am­gen de­buts new Pro­lia TV ad

Last year
Pharma

Bris­tol My­ers in­tro­duces re­al pa­tients in dig­i­tal and so­cial So­tyk­tu pso­ri­a­sis cam­paign

Last year
Pharma

FDA's up­dat­ed rules for drug ad­ver­tis­ing for TV and ra­dio near the fin­ish line

Last year
Pharma

Re­al Chem­istry taps two vet­er­ans to lead its cri­sis com­mu­ni­ca­tions and so­cial im­pact busi­ness­es

Last year
People

Ab­b­Vie dou­bles down on cor­po­rate aware­ness ef­forts in lat­est so­cial and dig­i­tal cam­paign

Last year
Pharma

CDC vac­cine com­mit­tee votes unan­i­mous­ly to rec­om­mend Sanofi and As­traZeneca's RSV im­mu­niza­tion for ba­bies

Last year
Pharma

Genen­tech up­dates spinal mus­cu­lar at­ro­phy ef­fort with new de­sign, so­cial me­dia and ‘Re­al Talk’

Last year
Pharma
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times